Now Undervalued, Should You Invest in Allergan (AGN)?

Mere weeks after its failed merger with Pfizer (PFE), global pharmaceutical company Allergan PLC (AGN), maker of Viagra and Botox, announced a new $10 billion share repurchase authorization. Allergan plans to complete the $40 billion sale of its generic pharmaceutical business to Pharmaceuticals...
Read More

Delta Air Lines (DAL)

Delta Air Lines (DAL) from Smart Investing in Turbulent Times Delta Air Lines (DAL) reported a stronger-than-expected third quarter last week. Key positives include robust free cash flow (enabling share repurchases and ongoing debt reduction), and low stock valuation vs. peers. The stock is about...
Read More